Rare diseases
Investigational molecules
Locations
Study of Acalabrutinib Alone or with Rituximab for Patients with Relapsed/Refractory Marginal Zone Lymphoma
ItalyStudy of Pembrolizumab and Sacituzumab Govitecan for Patients with Muscle-Invasive Bladder Cancer Unable or Unwilling to Use Cisplatin-Based Chemotherapy
ItalyStudy of durvalumab, carboplatin and etoposide combination therapy for patients with metastatic large-cell neuroendocrine lung cancer who have not received previous treatment
ItalyStudy of Durvalumab and Regorafenib for Patients with Stage IV Colorectal Cancer with No Evidence of Disease
ItalyStudy on Cabozantinib for Patients with Liver Cancer Not Responding to Previous Immune Treatments
ItalyStudy on the Safety and Effectiveness of EHSG-KF for Treating Full-Thickness Skin Defects in Adults and Children
ItalyStudy on Reducing Asthma Medication with Tezepelumab in Patients Aged 12 to 80 with Severe Asthma
ItalyStudy Comparing Sacituzumab Govitecan with Other Treatments for Patients with Advanced Unresectable Urothelial Cancer
ItalyStudy on Guselkumab for Healing in Crohn's Disease Patients
ItalyStudy of Inhaled Molgramostim for Adults with Autoimmune Pulmonary Alveolar Proteinosis
ItalyStudy of AZD7798 compared to placebo in patients with moderate to severe Crohn's disease
ItalyStudy on Datopotamab Deruxtecan and Osimertinib for Patients with Advanced Non-Small Cell Lung Cancer After Osimertinib Treatment
ItalyTell us about your condition – we search every trial in Europe and connect you with the right site.
